MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients

European Respiratory Journal

Volumn 15, Issue 6, 2000, Pages 1039-1045

  Viglio, S ^a   Iadarola, P ^a   Lupi, A ^a   Trisolini, R ^a   Tinelli, C ^a   Balbi, B ^b   Grassi, V ^b   Worlitzsch, D ^c   Doring G ^c   Meloni, F ^a   Meyer, K C ^d   Dowson, L ^e   Hill, S L ^e   Stockley, R A ^e   Luisetti, M ^a,f  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

1 Antitrypsin deficiency; Bronchiectasis; Chronic obstructive pulmonary disease; Cystic fibrosis; Lung elastin

Indexed keywords

DESMOSINE; ELASTIN; ISODESMOSINE;

ADULT; AGED; ALPHA ANTITRYPSIN DEFICIENCY; ARTICLE; CAPILLARY ELECTROPHORESIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS LINKING; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; LUNG COMPLIANCE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALPHA 1-ANTITRYPSIN DEFICIENCY; BRONCHIECTASIS; CROSS-LINKING REAGENTS; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; DESMOSINE; ELASTIN; ELECTROPHORESIS, CAPILLARY; EMPHYSEMA; EXTRACELLULAR MATRIX; FEMALE; HUMANS; ISODESMOSINE; LONGITUDINAL STUDIES; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED;

EID: 0034123654     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.01511.x     Document Type: Article

References (36)

1. Snider GL. Emphysema: the first two centuries - and beyond. A historical overview, with suggestions for future research: part 2. Am Rev Respir Dis 1992; 146: 1615-1622.
2. McElvaney NG, Birrer P, Chang-Stroman LM, Crystal RG. Neutrophils, neutrophil elastase and the fragile lung: the pathogenesis and therapeutic strategies relating to lung derangement in the common hereditary lung disorders. In: Grassi C, Travis J, Casali L, Luisetti M, eds. Biochemistry of Pulmonary Emphysema. London, Springer-Verlag, 1992; pp. 169-187.
3. Stockley RA, Hill SL, Burnett D. Proteinases in chronic lung infection. Ann N Y Acad Sci 1991; 624: 257-266.
4. Döring G. The role of neutrophil elastase in chronic inflammation. Am J Respir Crit Care Med 1994; 150: S114-S117.
5. Goldstein RA, Starcher BC. Urinary excretion of elastin peptides containing desmosine after intratracheal injection of elastase in hamsters. J Clin Invest 1978; 61: 1286-1290.
6. Stone PJ, Gottlieb DJ, O'Connor GT, et al. Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151: 952-959.
7. Stone PJ, Konstan MW, Berger M, Dorkin HL, Franzblau C, Snider GL. Elastin and collagen degradation products in urine of patients with cystic fibrosis. Am J Respir Crit Care Med 1995; 152: 157-162.
8. Stone PJ, Bryan-Rhadfi J, Lucey EC, et al. Measurement of urinary desmosine by isotope dilution and high performance liquid chromatography. Correlation between elastase-induced air-space enlargement in the hamster and urinary desmosine. Am Rev Respir Dis 1991; 144: 284-290.
9. Starcher B, Scott M. Fractionation of urine to allow desmosine analysis by radioimmunoassay. Ann Clin Biochem 1992; 29: 72-78.
10. Iadarola P, Lungarella G, Martorana PA, et al. Lung injury and degradation of extracellular matrix components by Aspergillus fumigatus serine proteinase. Exp Lung Res 1998; 24: 233-251.
11. Viglio S, Zanaboni G, Luisetti M, Cetta G, Guglielminetti M, Iadarola P. Micellar electrokinetic chromatography: a convenient alternative to colorimetric and high performance liquid chromatography detection to monitor protease activity. Electrophoresis 1998; 19: 2083-2089.
12. Viglio S, Luisetti M, Zanaboni G, et al. Simultaneous determination of Pseudomonas aeruginosa elastase, human leukocyte elastase and cathepsin G activities by micellar electrokinetic chromatography. J Chromatogr A 1999; 846: 125-134.
13. Viglio S, Zanaboni G, Luisetti M, et al. Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease. J Chromatogr B Biomed Sci Appl 1998; 714: 87-89.
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S78-S121.
15. Anthonisen NR, Manfreda J, Warren CPW, Hershfield ES, Harding GKM, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204.
16. Weatherly MR, Palmer CGS, Peters ME, et al. Wisconsin cystic fibrosis chest radiograph scoring system. Pediatrics 1993; 91: 488-495.
17. Meloni F, Ballabio PC, Pistorio A, et al. Urinary levels of bombesin-related peptides in a population sample from Northern Italy: potential role in the pathogenesis of chronic obstructive pulmonary disease. Am J Med Sci 1998; 315: 258-265.
18. Linder W, Waimer IW. Validated assays in the Journal of Chromatography B: an initial editorial position. J Chromatogr B Biomed Sci Appl 1986; 683: 133-134.
19. Giumelly P, Botton B, Friot R, Prima-Putra D, Atkinson J. Measurement of desmosine and isodesmosine by capillary zone electrophoresis. J Chromatogr A 1995; 710: 357-360.
20. Starcher B, Green M, Scott M. Measurement of urinary desmosine as an indicator of acute pulmonary disease. Respiration 1995; 62; 252-257.
21. Rosenbloom J. Biochemical/immunologic markers of emphysema. Ann N Y Acad Sci 1991; 624S: 7-12.
22. Selby C, Drost E, Wraith PK, McNee W. Neutrophil traffic through the lungs in man. Ann N Y Acad Sci 1991; 624: 353-354.
23. 1-Antitrypsin in infected and non-infected sputum. Am Rev Respir Dis 1979; 120: 1081-1086.
24. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992; 146: 1067-1083.
25. Mikami M, Llewellyn-Jones C, Bayley D, Hill SL, Stockley RA. The chemotactic activity of sputum from patients with bronchiectasis. Am J Respir Crit Care Med 1998; 157: 723-728.
26. Stockley RA, Hill SL, Morrison HM, Starkie CM. Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis. Thorax 1984; 39: 408-413.
27. Pelham F, Wewers M, Crystal RG, Buist AS, Janoff A. Urinary excretion of desmosine (elastin cross-links) in subjects with PiZZ alpha-1-antitrypsin deficiency, a phenotype associated with hereditary predisposition to pulmonary emphsyema. Am Rev Respir Dis 1985; 132: 821-823.
28. 1-Antitrypsin deficiency: memorandum from a WHO meeting. WHO Bull 1997; 75: 397-415.
29. Davies SF, Offord KP, Brown MG, Campe H, Niewoehner D. Urine desmosine is unrelated to cigarette smoking or to spirometric function. Am Rev Respir Dis 1983; 128: 473-475.
30. Gottlieb DJ, Stone PJ, Sparrow D, et al. Urinary desmosine excretion in smokers with and without rapid decline of lung function. The Normative Aging Study. Am J Respir Crit Care Med 1996; 154: 1290-1295.
31. Snider GL, Stone PJ, Lucey EC. The specific treatment of emphysema. Eur Respir J 1990; 3: Suppl. 9, 23s-28s.
32. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med 1996; 125: 605-613.
33. Cohen AB, Girard W, McIarty J, et al. A controlled trial of colchicine to reduce the elastase load in the lungs of cigarette smokers with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990; 142: 63-72.
34. Cohen AB, Girard W, McIarty J, et al. A controlled trial of colchicine to reduce the elastase load in the lungs of ex-cigarette smokers with chronic obstructive pulmonary disesae. Am Rev Respir Dis 1991; 143: 1038-1043.
35. Luisetti M, Sturani C, Sella D, et al. MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial. Eur Respir J 1996; 9: 1482-1486.
36. Stone PJ, Morris TA III, Franzblau C, Snider GL. Preliminary evidence that augmentation therapy diminishes degradation of cross-linked elastin in alpha-1-antitrypsin deficient humans. Respiration 1995; 62: 76-79.